Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
University of Colorado, Denver · with National Institute on Aging (NIA) · NCT06912984
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 242
- US sites recruiting
- 1
- Study start
- May 28, 2025
- Record last updated
- June 5, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of the proposed study is to understand the reasons for the variability in aerobic exercise (AE) training benefits on the vasculature in middle-age and older (MA/O) adults, including differences between men and women. To achieve this goal, a mechanistic randomized controlled (RCT) will be conducted, in which adults are randomized to 12-weeks intervention of AE or no-exercise Control. Our overall hypothesis is that the exercise response variation in vascular benefits is related to age and sex differences in the biological changes underlying vascular aging and/or the molecular transducers (i.e., circulating molecules) that communicate and coordinate the effects of AE on the vasculature in the periphery and brain. Because this is a mechanistic trial, the overall goal is not a single health-related outcome. Rather, the goal is to advance our understanding of the molecular signals and pathways underlying the systemic and local effects of AE on vascular health that may explain the variability in AE responses with age and sex. This knowledge will allow for the development of personalized age- and sex-specific AE recommendations, and/or provide insights into molecular targets that can be manipulated to enhance and/or mimic exercise in non-responders or in persons unable to exercise.
Being studied: Aerobic Exercise Training
Conditions: Aging; Physical Activity; Vascular Health
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Ability to provide consent;
- Man or woman >= 18 years;
- Willing to be randomized to an exercise or control intervention;
- No orthopedic limitations that would prevent the volunteer from performing treadmill or cycling exercise;
- No use of hormone therapy in postmenopausal women or in men (note, hormonal contraceptives in premenopausal women will be allowed);
- Healthy, as determined by medical history, physical examination, standard blood chemistries and ECG at rest and during a physician monitored graded exercise treadmill test;
- Sedentary or recreationally active (\<2 days/wk vigorous activity);
- No use of medications that might influence cardiovascular function (e.g., blood pressure and lipid lowering medications, metformin, insulin, sulfonylureas, etc.);
- No use of vitamins, supplements or anti-inflammatory medications, or willing to stop 1 month prior to enrollment and for the duration of the study;
Exclusion Criteria
- Contraindications to aerobic exercise;
- Diabetic or fasted glucose >126 mg/dL;
- Resting blood pressure >= 140/90 mmHg;
- Current or past history of cancer other than skin cancer;
- Preexisting or active cardiac, renal or hepatic disease;
- History of stomach ulcer or bleeding or epilepsy or nervous system and/or seizure disorder;
- Active or chronic infection;
- An abnormal resting ECG, angina and/or ECG evidence of acute myocardial ischemia during the exercise test (development of ST-segment depression of more than 0.3 mV that is either horizontal, downsloping, or slowly upsloping- less than 1 mvolt/sec and lasts more than 0.08 sec; ST elevation; chest pain or discomfort), bundle branch block, AV block greater than first degree, arrhythmias;
- Thyroid dysfunction, defined as ultrasensitive TSH \<0.5 or >5 mU/L. Participants with abnormal TSH values will be reconsidered for participation after follow-up with their PCP and initiation of thyroid replacement medications for at least 3 months;
- Smoking or tobacco use;
- Alcohol consumption > 14 drinks/week;
- Body mass index > 39kg/m2;
Recruiting US locations
University of Colorado Anschutz Medical Center, Clinical Translational Research Center and Exercise Research Laboratory
Aurora, CO 80045
Site contact: Kerrie Moreau, PhD · 303-724-1914 · kerrie.moreau@cuanschutz.edu
Study contacts (from the official record)
- Kerrie Moreau, PhD · (303)-724-1914 · kerrie.moreau@cuanschutz.edu
- Claire Cox · 303-724-1396 · claire.cox@cuanschutz.edu
Similar studies in Colorado
All healthy volunteers studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100